Drreddys Laboratories | RDY - Cash And Equivalent


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Drreddys Laboratories

Drreddys Laboratories reported INR5.78B in Cash and Equivalent for its fiscal quarter ending in March of 2023.


Cash And Equivalent Change
ANI Pharmaceuticals ANIP:US USD 67.76M 19.53M
Bayer BAYN:GR EUR 4.85B 317M
Catalent CTLT:US USD 442M 161M
Corcept Therapeutics CORT:US USD 299.94M 233.61M
Drreddys Laboratories RDY:US INR 5.78B 5.15B
Endo International ENDP:US USD 903.61M 115.27M
GlaxoSmithKline GSK:LN GBP 2.89B 833M
Hikma Pharmaceutical HIK:LN USD 1000K 22M
Horizon Pharma HZNP:US USD 2.31B 41.2M
Lonza Group LONN:SW CHF 1.34B 187M
Novartis NOVN:VX USD 12B 4.48B
Pacira PCRX:US USD 35.54M 68.59M
Phibro Animal Health PAHC:US USD 37.24M 31.18M
Prestige Brands PBH:US USD 58.49M 27.87M
Richter Gedeon RICHT:HB HUF 85.99B 6.27B
Supernus Pharmaceuticals SUPN:US USD 58.44M 34.68M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 2.14B 658M